Skip to content

RAREULTRAGENYX PHARMACEUTICAL IN

CUSIP 90400D108 · common stock

1 tracked investor held ULTRAGENYX PHARMACEUTICAL IN (RARE) at the end of Q3 2026, worth $4.5M. The largest holder was Adar1 Capital Management, with 0.2% of its portfolio. Adar1 Capital Management opened a new position this quarter.

Holders · Q3 2026
1
New holders
1
Value held
$4.5M
Quarter-end price (est.)
$15.03

Investors holding RARE · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.19%300,000$4.5MNEW

Options

InvestorTypeUnderlying sharesValueChange
Adar1 Capital ManagementCall20,000$300.6KHOLD

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Sands Capital Management0.39%3,158,368$105.5MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026111$4.5M$15.03
Q2 2026101$105.5M$33.39
Q1 2026212$67.6M$20.95
Q4 2025300$148.5M$23.00